Translational Medicine

Research Frontiers in Checkpoint Kinase Inhibitor Development Pipeline

Discovery and optimization of selective inhibitors targeting DNA damage response checkpoints to enhance chemotherapy and immunotherapy efficacy in cancer.

All Translational Medicine PhD categories